Matinas BioPharma Holdings, Inc. (MTNB)

USD 0.59

(-0.45%)

Revenue Summary of Matinas BioPharma Holdings, Inc.

  • Matinas BioPharma Holdings, Inc.'s latest annual revenue in 2023 was 1.09 Million USD , down -65.62% from previous year.
  • Matinas BioPharma Holdings, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Matinas BioPharma Holdings, Inc. reported a annual revenue of 3.18 Million USD in annual revenue 2022, up 9464.1% from previous year.
  • Matinas BioPharma Holdings, Inc. reported a annual revenue of 33.33 Thousand USD in annual revenue 2021, down -78.95% from previous year.
  • Matinas BioPharma Holdings, Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Matinas BioPharma Holdings, Inc. reported a quarterly revenue of 1.09 Million USD for 2023 Q1, up 3.1% from previous quarter.

Annual Revenue Chart of Matinas BioPharma Holdings, Inc. (2023 - 2012)

Historical Annual Revenue of Matinas BioPharma Holdings, Inc. (2023 - 2012)

Year Revenue Revenue Growth
2023 1.09 Million USD -65.62%
2022 3.18 Million USD 9464.1%
2021 33.33 Thousand USD -78.95%
2020 158.33 Thousand USD 75.93%
2019 90 Thousand USD -24.84%
2018 119.75 Thousand USD -20.0%
2017 149.68 Thousand USD 0.0%
2016 - USD -100.0%
2015 194.49 Thousand USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Revenue Comparison of Matinas BioPharma Holdings, Inc.

Name Revenue Revenue Difference
AIM ImmunoTech Inc. 202 Thousand USD -442.574%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Armata Pharmaceuticals, Inc. 4.52 Million USD 75.8%
Actinium Pharmaceuticals, Inc. 81 Thousand USD -1253.086%
Azitra, Inc. 686 Thousand USD -59.767%
Can-Fite BioPharma Ltd. 743 Thousand USD -47.51%
Chromocell Therapeutics Corporation - USD -Infinity%
Calidi Biotherapeutics, Inc. - USD -Infinity%
CEL-SCI Corporation - USD -Infinity%
iBio, Inc. 225 Thousand USD -387.111%
Lineage Cell Therapeutics, Inc. 8.94 Million USD 87.747%
MAIA Biotechnology, Inc. - USD -Infinity%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -1569.408%
NovaBay Pharmaceuticals, Inc. 14.72 Million USD 92.557%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. 37.65 Thousand USD -2810.791%
BiomX Inc. -357 Thousand USD 407.003%
BiomX Inc. -357 Thousand USD 407.003%
Protalix BioTherapeutics, Inc. 65.49 Million USD 98.327%
Palatin Technologies, Inc. 4.49 Million USD 75.591%
Scorpius Holdings, Inc. 6.99 Million USD 84.331%